On December 12, 2020, after an explicit, evidence-based review of all available data, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years for the prevention of COVID-19.
The CDC concurs: The recommendation for the Pfizer-BioNTech COVID-19 vaccine should be implemented in conjunction with ACIP’s interim recommendation for allocating initial supplies of COVID-19 vaccines.
Beginning Thursday, December 17, 2020, call backs will be delayed until Tuesday, January 5, 2021. For assistance, please call 706-405-4775, Monday - Friday, 8:00 am - 7:00 pm (Closed Christmas and New Year's Day)
Registration and a more detailed agenda will be available in January.
The Conference will reinforce proven strategies, address emerging challenges, and find innovative new ways to solve problems. Workshops and plenaries have been developed in concert with people who have experienced homelessness, and with a focus on race and equity.